Qch Regular Strength Antacid 509 Liquid
NDC Package 83324-121-12
Package Information
Qch Regular Strength Antacid 509 (aluminum hydroxide, magnesium hydroxide, simethicone) liquids is shake well before usemL = milliliteradults and children 12 years and older: take 10 mL to 20 mL four times a day, or as directed by a doctorchildren under 12 years: consult a doctor. This formulation utilizes a liquid delivery system. Marketed by Chain Drug Marketing Association Inc., this product is identified by NDC 83324-121 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 307746 - aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG in 5 mL Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 1200 MG / milk of magnesia 1200 MG / dimethicone 120 MG per 30 ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 200 MG / milk of magnesia 200 MG / dimethicone 20 MG per 5 ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 400 MG / milk of magnesia 400 MG / dimethicone 40 MG per 10 ML Oral Suspension
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Skin Barrier Activity - [PE] (Physiologic Effect)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 83324 - Chain Drug Marketing Association Inc.
- 83324-121 - Qch Regular Strength Antacid 509
- 83324-121-12 - 355 mL in 1 BOTTLE
- 83324-121 - Qch Regular Strength Antacid 509
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83324-121-12 identifies a specific commercial package of 355 ml in 1 bottle of Qch Regular Strength Antacid 509, a human over the counter drug labeled by Chain Drug Marketing Association Inc.. This liquid is formulated for oral use and contains aluminum hydroxide; dimethicone; magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Marketing Association Inc. on August 27, 2024. The current certification is valid through December 31, 2026.
How is this Chain Drug Marketing Association Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83324012112. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 355 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.